Market Closed -
Bombay S.E.
03:30:55 27/06/2024 pm IST
|
5-day change
|
1st Jan Change
|
25.15
INR
|
-3.64%
|
|
+6.12%
|
+19.82%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
14,301
|
11,266
|
1,044
|
1,329
|
944.6
|
570.2
|
Enterprise Value (EV)
1 |
19,639
|
17,948
|
8,721
|
9,030
|
8,595
|
8,257
|
P/E ratio
|
24.9
x
|
12.7
x
|
2.4
x
|
-1.21
x
|
-15
x
|
-2.31
x
|
Yield
|
0.17%
|
0.33%
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
4.13
x
|
2.73
x
|
0.39
x
|
3.02
x
|
1.44
x
|
1.54
x
|
EV / Revenue
|
5.67
x
|
4.35
x
|
3.27
x
|
20.5
x
|
13.1
x
|
22.2
x
|
EV / EBITDA
|
18.6
x
|
13
x
|
11.4
x
|
-1,092
x
|
92.6
x
|
-48
x
|
EV / FCF
|
-14.2
x
|
-7.88
x
|
-11.3
x
|
7.37
x
|
31.8
x
|
59.7
x
|
FCF Yield
|
-7.04%
|
-12.7%
|
-8.81%
|
13.6%
|
3.14%
|
1.67%
|
Price to Book
|
1.93
x
|
1.21
x
|
0.11
x
|
0.15
x
|
0.11
x
|
0.07
x
|
Nbr of stocks (in thousands)
|
24,600
|
24,600
|
24,600
|
26,571
|
26,571
|
26,571
|
Reference price
2 |
581.4
|
458.0
|
42.45
|
50.00
|
35.55
|
21.46
|
Announcement Date
|
26/09/18
|
06/09/19
|
05/12/20
|
30/06/21
|
26/09/22
|
29/09/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,462
|
4,128
|
2,668
|
440.1
|
656.5
|
371.1
|
EBITDA
1 |
1,054
|
1,383
|
763.3
|
-8.267
|
92.8
|
-172
|
EBIT
1 |
903.2
|
1,223
|
597.1
|
-187.2
|
-86.3
|
-351.5
|
Operating Margin
|
26.09%
|
29.62%
|
22.38%
|
-42.53%
|
-13.14%
|
-94.7%
|
Earnings before Tax (EBT)
1 |
735.2
|
1,062
|
519.7
|
-1,105
|
-74.14
|
-261.3
|
Net income
1 |
524
|
884.9
|
470.2
|
-1,096
|
-62.82
|
-246.8
|
Net margin
|
15.14%
|
21.44%
|
17.62%
|
-248.98%
|
-9.57%
|
-66.5%
|
EPS
2 |
23.31
|
35.97
|
17.70
|
-41.24
|
-2.364
|
-9.290
|
Free Cash Flow
1 |
-1,383
|
-2,279
|
-768.7
|
1,225
|
270.2
|
138.2
|
FCF margin
|
-39.95%
|
-55.21%
|
-28.81%
|
278.3%
|
41.16%
|
37.24%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
291.16%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
1.000
|
1.500
|
-
|
-
|
-
|
-
|
Announcement Date
|
26/09/18
|
06/09/19
|
05/12/20
|
30/06/21
|
26/09/22
|
29/09/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
5,338
|
6,682
|
7,676
|
7,702
|
7,651
|
7,687
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
5.064
x
|
4.833
x
|
10.06
x
|
-931.6
x
|
82.44
x
|
-44.7
x
|
Free Cash Flow
1 |
-1,383
|
-2,279
|
-769
|
1,225
|
270
|
138
|
ROE (net income / shareholders' equity)
|
9.43%
|
10.6%
|
4.95%
|
-12%
|
-0.73%
|
-2.93%
|
ROA (Net income/ Total Assets)
|
5.36%
|
5.22%
|
2.2%
|
-0.66%
|
-0.32%
|
-1.35%
|
Assets
1 |
9,782
|
16,961
|
21,334
|
1,65,082
|
19,767
|
18,307
|
Book Value Per Share
2 |
301.0
|
378.0
|
395.0
|
324.0
|
322.0
|
313.0
|
Cash Flow per Share
2 |
5.620
|
0.3200
|
0.4200
|
0.3300
|
0.5800
|
0.3400
|
Capex
1 |
1,671
|
2,887
|
1,305
|
-
|
-
|
-
|
Capex / Sales
|
48.26%
|
69.94%
|
48.91%
|
-
|
-
|
-
|
Announcement Date
|
26/09/18
|
06/09/19
|
05/12/20
|
30/06/21
|
26/09/22
|
29/09/23
|
|
1st Jan change
|
Capi.
|
---|
| +19.82% | 82.98L | | +20.91% | 6.87TCr | | -4.97% | 4.65TCr | | +24.89% | 4.46TCr | | +32.42% | 2.81TCr | | +8.74% | 1.92TCr | | +15.57% | 1.73TCr | | -12.37% | 1.51TCr | | -29.11% | 1.42TCr | | -31.09% | 1.22TCr |
Other Specialty Chemicals
|